Gourav Chakraborty Source Confirmed

OverviewAI-generated summary

Gourav Chakraborty's research focuses on computational approaches to understand molecular mechanisms relevant to health and disease. He has investigated drug resistance in bacteria, including <i>in silico</i> structural and mechanical insights into bedaquiline resistance associated with mutations in <i>atpE</i>, <i>mmpR5</i>, and <i>pepQ</i>, and computational approaches to simulate delamanid and pretomanid binding to mycobacterial F420 redox cycling proteins. His work also explores protein-protein interactions, such as the molecular basis of 14–3–3 interaction with α-synuclein and the modulation of 14-3-3η/Parkin interaction. Additionally, Chakraborty has explored the design of nanoparticles for therapeutic applications and the optimization of oil detachment from surfaces using molecular dynamics and machine learning. He has published 17 papers, with an h-index of 3 and 22 total citations. Chakraborty collaborates with researchers at Arkansas State University, including Viswanathan Rajagopalan and Sankalpa Chakraborty.

Metrics

• h-index: 3
• Publications: 17
• Citations: 22